|
1
|
Marrero JA, Kulik LM, Sirlin CB, Zhu AX,
Finn RS, Abecassis MM, Roberts LR and Heimbach JK: Diagnosis,
staging, and management of hepatocellular carcinoma: 2018 practice
guidance by the American association for the study of liver
diseases. Hepatology. 68:723–750. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kudo M, Finn RS, Qin S, Han KH, Ikeda K,
Pscaglia F, Bari A, Park JW, Han G, Jassem J, et al: Lenvatinib
versus sorafenib in first-line treatment of patients with
unresectable hepatocellular carcinoma: A randomised phase 3
non-inferiority trial. Lancet. 391:1163–1173. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davydov M and Krikorian AD:
Eleutherococcus senticosus (Rupr. & Maxim.) Maxim.
(Araliaceae) as an adaptogen: A closer look. J Ethnopharmacol.
72:345–393. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nishibe S, Kinoshita H, Takeda H and Okano
G: Phenolic compounds from stem bark of Acanthopanax
senticosus and their pharmacological effect in chronic swimming
stressed rats. Chem Pharm Bull (Tokyo). 38:1763–1765. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee S, Son D, Ryu J, Lee YS, Jung SH, Kang
J, Lee SY, Kim HS and Shin KH: Anti-oxidant activities of
Acanthopanax senticosus stems and their lignan components.
Arch Pharm Res. 27:106–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jang MH, Shin MC, Kim YJ, Kim CJ and Chung
JH: Protective effect of Acanthopanax senticosus against
ethanol-induced apoptosis of human neuroblastoma cell line SK-N-MC.
Am J Chin Med. 31:379–388. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee S, Shin DS, Oh KB and Shin KH:
Antibacterial compounds from the leaves of Acanthopanax
senticosus. Arch Pharm Res. 26:40–42. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yi JM, Hong SH, Kim JH, Kim HK, Song HJ
and Kim HM: Effect of Acanthopanax senticosus stem on mast
cell-dependent anaphylaxis. J Ethnopharmacol. 79:347–352. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu KY, Wu YC, Liu IM, Yu WC and Cheng JT:
Release of acetylcholine by syringin, an active principle of
Eleutherococcus senticosus, to raise insulin secretion in
Wistar rats. Neurosci Lett. 434:195–199. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fujikawa T, Yamaguchi A, Morita I, Takeda
H and Nishibe S: Protective effects of Acanthopanax
senticosus Harms from Hokkaido and its components on gastric
ulcer in restrained cold water stressed rats. Biol Pharm Bull.
19:1227–1230. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takahashi Y, Tanaka M, Murai R,
Kuribayashi K, Kobayashi D, Yanagihara N and Watanabe N:
Prophylactic and therapeutic effects of Acanthopanax
senticosus Harms extract on murine collagen-induced arthritis.
Phytother Res. 28:1513–1519. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu SM, Li XZ, Zhang SN, Yang ZM, Wang KX,
Lu F, Wang CZ and Yuan CS: Acanthopanax senticosus protects
structure and function of mesencephalic mitochondria in a mouse
model of Parkinson's disease. Chin J Integr Med. 24:835–843. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hibasami H, Fujikawa T, Takeda H, Nihibe
S, Satoh T, Fujisawa T and Nakashima K: Induction of apoptosis by
Acanthopanax senticosus HARMS and its component, sesamin in
human stomach cancer KATO III cells. Oncol Rep. 7:1213–1216.
2000.PubMed/NCBI
|
|
14
|
Siao AC, Hou CW, Kao YH and Jeng KC:
Effect of sesamin on apoptosis and cell cycle arrest in human
breast cancer mcf-7 cells. Asian Pac J Cancer Prev. 16:3779–3783.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang QY, Zhong H, Chen FY, Zhang MY, Cai
JY and Xhong JH: A preliminary study on epigenetic regulation of
Acanthopanax senticosus in leukemia cell lines. Exp Hematol.
44:466–473. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamazaki T, Shimosaka S, Sasaki H,
Matsumura T, Tukiyama T and Tokiwa T:
(+)-Syringaresinol-di-O-β-D-glucoside, a phenolic compound from
Acanthopanax senticosus Harms, suppresses proinflammatory
mediators in SW982 human synovial sarcoma cells by inhibiting
activating protein-1 and/or nuclear factor-κB activities. Toxicol
in Vitro. 21:1530–1537. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Miyazaki S, Oikawa H, Takekoshi H,
Hoshizaki M, Ogata M and Fujikawa T: Anxiolytic effects of
Acanthopanax senticosus HARMS occur via regulation of
autonomic function and activate hippocampal BDNF-TrkB signaling.
Molecules. 24:1322018. View Article : Google Scholar
|
|
18
|
Ishikawa K, Kawano Y, Arihara Y, Kubo T,
Takada K, Murase K, Miyanishi K, Kobune M and Kato J: BH3 profiling
discriminates the antiapoptotic status of 5-fluoro-uracil-resistant
colon cancer cells. Oncol Rep. 42:2416–2425. 2019.PubMed/NCBI
|
|
19
|
Kamihara Y, Takada K, Sato T, Kawano Y,
Murase K, Arihara Y, Kikuchi S, Hayasaka N, Usami M, Iyama S, et
al: The iron chelator deferasirox induces apoptosis by targeting
oncogenic Pyk2/β-catenin signaling in human multiple myeloma.
Oncotarget. 7:64330–64341. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saito T, Nishida M, Saito M, Tanabe A,
Eitsuka T, Yuan SH, Ikekawa N and Nishida H: The fruit of
Acanthopanax senticosus (Rupr. et Maxim.) Harms improves
insulin resistance and hepatic lipid accumulation by modulation of
liver adenosine monophosphate-activated protein kinase activity and
lipogenic gene expression in high-fat diet-fed obese mice. Nutr
Res. 36:1090–1097. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Debnath J, Baehrecke EH and Kroemer G:
Does autophagy contribute to cell death? Autophagy. 1:66–74. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Espert L, Denizot M, Grimaldi M,
Robert-Hebmann V, Gay B, Varbano M, Codogno P and Biard-Piechaczyk
M: Autophagy is involved in T cell death after binding of HIV-1
envelope proteins to CXCR4. J Clin Invest. 116:2161–2172. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shimizu S, Kanaseki T, Mizushima N, Mizuta
T, Arakawa-Kobayashi S, Thompson CB and Tsujimoto Y: Role of Bcl-2
family proteins in a non-apoptotic programmed cell death dependent
on autophagy genes. Nat Cell Biol. 6:1221–1228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mizushima N and Yoshimori T: How to
interpret LC3 immunoblotting. Autophagy. 3:542–545. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mizushima N, Yoshimori T and Levine B:
Methods in mammalian autophagy research. Cell. 140:313–326. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Iwashita H, Sakurai HT, Nagahora N,
Ishiyama M, Shioji K, Sasamoto K, Okuma K, Shimizu S and Ueno Y:
Small fluorescent molecules for monitoring autophagic flux. FEBS
Lett. 592:559–567. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Matsunaga K, Saitoh T, Tabata K, Omori H,
Satoh T, Kurotori N, Maejima I, Shirahama-Noda K, Ichimura T, Isobe
T, et al: Two Beclin 1-binding proteins, Atg14L and Rubicon,
reciprocally regulate autophagy at different stages. Nat Cell Biol.
11:385–396. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Suzuki A, Kakisaka K, Suzuki Y, Wang T and
Takikawa Y: C-Jun N-terminal kinase-mediated Rubicon expression
enhances hepatocyte lipoapoptosis and promotes hepatocyte
ballooning. World J Gastroenterol. 22:6509–6519. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang H, Sun B, Zhang Z, Chen J, Hao Q, Sun
Y, Yang Y, Wang Z and Pei J: Effects of Acanthopanax
senticosus polysaccharide on the proliferation, apoptosis and
cell cycle in human HepG2 cells. Pharmazie. 71:201–204.
2016.PubMed/NCBI
|
|
30
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Y, Xu W, Yan Z, Zhao W, Mi J, Li J
and Yan H: Metformin induces autophagy and G0/G1 phase cell cycle
arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
J Exp Clin Cancer Res. 37:632018. View Article : Google Scholar : PubMed/NCBI
|
